These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo. Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865 [TBL] [Abstract][Full Text] [Related]
24. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo. Zhou J; Peng C; Li B; Wang F; Zhou C; Hong D; Ye F; Cheng X; Lü W; Xie X Gynecol Oncol; 2012 Feb; 124(2):296-302. PubMed ID: 22056554 [TBL] [Abstract][Full Text] [Related]
25. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. Aigner A J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079 [TBL] [Abstract][Full Text] [Related]
33. Triton X-100-Modified Adenosine Triphosphate-Responsive siRNA Delivery Agent for Antitumor Therapy. Fan X; Zhao X; Su W; Tang X Mol Pharm; 2020 Oct; 17(10):3696-3708. PubMed ID: 32803981 [TBL] [Abstract][Full Text] [Related]
34. Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles. Kim JS; Kim MW; Kang SJ; Jeong HY; Park SI; Lee YK; Kim HS; Kim KS; Park YS Int J Nanomedicine; 2018; 13():4817-4830. PubMed ID: 30214190 [TBL] [Abstract][Full Text] [Related]
35. Journey of siRNA: Clinical Developments and Targeted Delivery. Nikam RR; Gore KR Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585 [TBL] [Abstract][Full Text] [Related]
37. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy. Xu C; Liu W; Hu Y; Li W; Di W Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871 [TBL] [Abstract][Full Text] [Related]
38. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles. Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601 [TBL] [Abstract][Full Text] [Related]
39. Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491 [TBL] [Abstract][Full Text] [Related]
40. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth. Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]